It is also noteworthy that pharmacological inhibition of STAT3 has been demonstrated to effectively suppress bladder cancer cell progression in vitro and in vivo, thus validating STAT3 blockage as a potential strategy for bladder cancer therapy [18,19,20,21]. The gene discussed is STAT3; the disease is urinary bladder carcinoma.